| Literature DB >> 35864470 |
Charlene Lee1, Jonathan Beavers2, Jonathan Pham3, Liam Hackett2,4, Joseph Miller5,6, Paul Buntine2,4.
Abstract
BACKGROUND: A large number of CT brain (CTB) scans are ordered in the ED for older patients with a confirmed or possible head strike but no ongoing symptoms of a head injury. This study aimed to evaluate the effect of the Canadian CT head rule supplemented by the original published minimum inclusion criteria to assist clinician assessment of the need for CTB following minimal trauma fall in patients presenting from residential aged care facilities to a major metropolitan emergency department (ED).Entities:
Keywords: Brain; Canadian CT head rule; Clinical score; Computed tomography; Decision support techniques; Emergency; Falls; Geriatric; Head injury; Intracranial haemorrhage; Residential aged care
Mesh:
Year: 2022 PMID: 35864470 PMCID: PMC9306092 DOI: 10.1186/s12877-022-03284-0
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Fig. 1Diagnostic support tool implemented in the Emergency Department
Baseline characteristics of pre- and post-intervention groups
| 2018 (Pre-intervention) | 2019 (Post-intervention) | ||
|---|---|---|---|
| Age range | 89 (85–92) | 88 (84–93) | 0.02 |
| median (IQR) | |||
| Gender n (%) | 0.00 | ||
| Female | 134 (57.5%) | 173 (71.8%) | |
| Male | 99 (42.5%) | 68 (28.2%) | |
Medication total median (IQR) | 7 (4–11) | 8 (5–11) | 0.36 |
| Medication missing n (%) | 24 (10.3%) | 23 (9.5%) | 0.78 |
| Cognitive impairment n (%) | 151 (64.8%) | 183 (75.9%) | 0.01 |
| Mobility prior to fall n (%) | 0.02 | ||
Non-ambulant Ambulant Not documented | 41 (17.6%) 176 (75.5%) 16 (6.9%) | 24 (10.0%) 210 (87.1%) 7 (2.9%) | |
| FRAT risk n (%) | 0.00 | ||
High risk Not documented | 191 (82.0%) 42 (18.0%) | 224 (93.0%) 17 (7.0%) | |
| Anticoagulation n (%) | 0.66 | ||
Anticoagulation No anticoagulation Not documented | 108 (46.4%) 117 (50.2%) 8 (3.4%) | 103 (42.7%) 131 (54.4%) 7 (2.9%) | |
| Type of anticoagulation n (%) | 0.00 | ||
Antiplatelet DAPT Warfarin DOAC Antiplatelet + warfarin DAPT + DOAC or warfarin | 64 (27.5%) 1 (0.4%) 17 (7.3%) 18 (7.7%) 5 (2.1%) 0 (0.0%) | 48 (19.9%) 7 (2.9%) 12 (5.0%) 33 (13.7%) 0 (0%) 0 (0%) | |
LMWH Antiplatelet + LMWH Antiplatelet + DOAC | 0 (0%) 2 (0.9%) 1 (0.4%) | 0 (0%) 0 (0%) 3 (1.2%) | |
| Witnessed fall n (%) | 0.13 | ||
Witnessed Not documented | 21 (9.0%) 15 (6.4%) | 26 (10.8%) 27 (11.2%) | |
| Headstrike* n (%) | 0.75 | ||
Headstrike Not documented | 110 (47.2%) 78 (33.5%) | 118 (49.0%) 73 (30.3%) | |
| Head injury** n (%) | 0.02 | ||
Head injury Not documented | 86 (37.0%) 89 (38.2%) | 105 (43.6%) 63 (26.1%) | |
| Late presentation n (%) *** | 1 (0.4%) | 0 (0%) | 0.49 |
| LOC n (%) | 0.33 | ||
LOC Not documented | 2 (0.9%) 121 (52.0%) | 6 (2.5%) 129 (53.5%) | |
| Headache n (%) | 0.87 | ||
Headache Not documented | 14 (6.0%) 167 (71.7%) | 15 (6.2%) 177 (73.4%) | |
| Vomiting n (%) | 0.08 | ||
Vomiting Not documented | 10 (4.3%) 191 (82.0%) | 9 (3.7%) 180 (74.7%) | |
| Neurological deficits n (%) | 4 (1.7%) | 5 (2.1%) | 0.78 |
| Change in GCS n (%) | 0.19 | ||
Change in GCS No change in GCS Not documented | 23 (9.9%) 160 (68.7%) 50 (21.5%) | 23 (9.5%) 149 (61.8%) 69 (28.6%) | |
| GCS in ED n (%) | 0.45 | ||
Not documented < 13 ≥13 | 6 (2.6%) 27 (11.5%) 200 (85.8%) | 2 (0.8%) 18 (7.4%) 221 (91.7%) |
FRAT Falls Risk Assessment Tool, DAPT Dual antiplatelet therapy, DOAC Direct oral anticoagulant, LMWH Low molecular weight heparin, LOC Loss of consciousness, GCS Glasgow Coma Score
* ‘Headstrike’: confirmation that the patient actually hit their head when they fell
** ‘Head injury’: documentation of a visible injury (e.g., bruising or a laceration) associated with a headstrike
*** ‘Late presentation’: patients who presented with an intracranial haemorrhage following a time lag from their initial fall injury. This was captured by reviewing 2 weeks of medical records prior to the index presentation to determine if there had been any previous fall injury
Comparison of pre- and post-intervention outcomes
| 2018 | 2019 | ||||||
|---|---|---|---|---|---|---|---|
| ( | % | ( | % | Difference | |||
| ED CTB performed | 134 | 57.0% | 90 | 37.3% | 19.7% | < 0.01** | |
| Confirmed ICH on ED CTB | 5 / 134 | 3.7% | 5 / 90 | 5.6% | 1.9% | 0.52 | |
| Chemical restraint used in ED CTB | 4 / 134 | 3.0% | 2 / 90 | 2.2% | 0.8% | 1.0 | |
| Physical restraint used in ED CTB | 0 / 134 | 0.0% | 0 / 90 | 0.0% | 0.0% | – | |
| Missed presentation** | 1 | 0.4% | 2 | 0.8% | −0.4% | 1.0 | |
| Ward CTB performed | 14/79 | 17.7% | 13/69 | 18.8% | −1.1% | 0.86 | |
| Abnormal ward CTB | 3 / 14 | 21.4% | 3 / 13 | 23.1% | −2.3% | 1.0 | |
| ICH on ward CTB | 1 / 14 | 7.1% | 2 / 13 | 15.4% | −8.3% | 0.60 | |
| Neurosurgical intervention | 0 / 134 | 0.0% | 0 / 90 | 0.0% | 0.0% | – | |
ED Emergency Department, CTB Computed tomography of the brain, ICH Intracranial haemorrhage, Ward CTB = CTBs subsequently performed on patients who were admitted to the ward from ED
** ‘Missed presentation’: patients who represented with an intracranial haemorrhage not diagnosed on the initial fall presentation. This was captured by reviewing two weeks of medical records following the index presentation
Fig. 2Flow diagrams representing outcomes for diagnosed intracranial haemorrhages in the pre- and post-intervention groups. : ‘Medical management’ refers to pharmacological management, which may include alteration to the patient’s pre-existing medications or prescription of a reversal agent to anticoagulant therapy
Fig. 3Flow diagrams representing progress of study participants after ED treatment in the pre- and post-intervention groups